IDx Technologies founder and CEO Michael Abramoff is succeeding Gary Seamans as executive chairman as the Coralville-based medical company announced new leadership appointments across its executive leadership team. Other appointments include John Bertrand succeeding Abramoff as CEO; Seth Rainford being appointed president and COO; and Danika Simonson being hired in the newly created chief of staff position. […]
Coralville-based IDx Technologies has appointed former LabCorp executive Seth Rainford as its new president of global markets, the Corridor Business Journal reports. Rainford will be charged with expanding market opportunities and driving operational excellence at IDx, which last April received clearance from the FDA for the first autonomous AI diagnostic system in any field of medicine. […]
IDx, a Coralville startup that developed the first FDA-authorized artificial intelligence diagnostics system, announced this week that the American Medical Association’s (AMA) Current Procedural Terminology (CPT) Editorial Panel has accepted a new category 1 CPT code for automated point-of-care retinal imaging. This new code, submitted by the American Academy of Ophthalmology (AAO) with the support […]
Coralville startup becomes the first FDA-authorized artificial intelligence diagnostics system One of the first FDA-authorized artificial intelligent solutions in ophthalmology sprouted in the laboratories of University of Iowa. The idea for advanced technology to help patients who could be going blind had been planted years earlier – first in the Netherlands, by an ophthalmology medical […]
Cultivation Corridor Executive Director Billi Hunt presented the 2019 Cultivation Corridor Iowa Biotech Leader Award to Dr. Michael Abramoff, founder and CEO of IDx Technologies. Abramoff accepted the award on Tuesday during a reception at Partnering for Growth Biotech Innovation Showcase and Forum, an annual conference by the Iowa Biotechnology Association (IowaBIO). The award recognizes […]
IDx-DR, an artificial intelligence system that detects diabetic retinopathy, is expanding to new healthcare settings since the FDA first cleared the AI system to go to market in April 2018, startup IDx of Coralville reports. IDx-DR is now in use in clinics focusing on endocrinology, internal medicine, diabetes education, community health, diagnostics labs and diabetes […]
Coralville company IDx, the first FDA-cleared autonomous AI diagnostic system, announced a new agreement with ophthalmic device manufacturer TopCon to scale delivery of the IDx diagnostics system for market, reports the Corridor Business Journal. The agreement grants exclusive rights to IDx in the U.S. as the only autonomous AI company permitted to sell products with […]
IDx: Secured $33 million in venture capital funding. Participated: 8VC, Optum Ventures, Alpha Edison and Heritage Provider Network. Based in Coralville. Meet FUNDED LATELY: Our peek into the awards/investment circle for Iowa’s promising startups. Do you know someone who should be featured here? Send an email to katehayden@bpcdm.com with the startup name, amount, contact information, and the contact […]
The University of Iowa Hospitals and Clinics will be the first in the state to employ a Coralville company’s artificial intelligence diagnostics when scanning for diabetic retinopathy, the Cedar Rapids Gazette reports. The device, called IDx-DR and developed by IDx, received approval from the U.S. Food and Drug Administration in April. The technology takes images […]
IDx, a University of Iowa spinout company based in Coralville, has received FDA approval to market IDx-DR, the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. IDx recently announced a move to larger quarters in the Oakdale Research […]